10-Q Filing

BEONE MEDICINES LTD. CIK: 1651308 Q1 2022

Filing Information

Form Type	10-Q
Accession Number	`0001651308-22-000071`
Period End Date	20220331
Filing Date	20220509
Fiscal Year	2022
Fiscal Period	Q1
XBRL Instance	bgne-20220331_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 93 Income Statement 40 Cash Flow Statement 79 Stockholders Equity 21 Comprehensive Income 10

Balance Sheet 93 line items

Line Item	Tag	Value	Unit	Period
Ordinary shares, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Ordinary shares, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$4.35B	USD	Point-in-time
Ordinary shares, shares authorized (in shares)	`CommonStockSharesAuthorized`	9.50B	shares	Point-in-time
Ordinary shares, shares authorized (in shares)	`CommonStockSharesAuthorized`	9.50B	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.90B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$4.38B	USD	Point-in-time
Short-term restricted cash	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$330.00K	USD	Point-in-time
Short-term restricted cash	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$328.00K	USD	Point-in-time
Short-term restricted cash	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$305.00K	USD	Point-in-time
Ordinary shares, shares issued (in shares)	`CommonStockSharesIssued`	1.33B	shares	Point-in-time
Ordinary shares, shares issued (in shares)	`CommonStockSharesIssued`	1.33B	shares	Point-in-time
Short-term investments	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$2.24B	USD	Point-in-time
Short-term investments	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$1.90B	USD	Point-in-time
Ordinary shares, shares outstanding (in shares)	`CommonStockSharesOutstanding`	1.33B	shares	Point-in-time
Ordinary shares, shares outstanding (in shares)	`CommonStockSharesOutstanding`	1.33B	shares	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$483.11M	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$190.80M	USD	Point-in-time
Inventories	`InventoryNet`	$245.63M	USD	Point-in-time
Inventories	`InventoryNet`	$242.63M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$270.17M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$266.44M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$7.61B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$6.95B	USD	Point-in-time
Long-term restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$8.28M	USD	Point-in-time
Long-term restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$6.96M	USD	Point-in-time
Long-term restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$6.88M	USD	Point-in-time
Property, plant and equipment, net	`PropertyPlantAndEquipmentNet`	$624.67M	USD	Point-in-time
Property, plant and equipment, net	`PropertyPlantAndEquipmentNet`	$587.61M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$115.50M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$117.43M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$45.81M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$46.68M	USD	Point-in-time
Deferred tax assets	`DeferredIncomeTaxAssetsNet`	$110.42M	USD	Point-in-time
Deferred tax assets	`DeferredIncomeTaxAssetsNet`	$115.76M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$163.05M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$164.55M	USD	Point-in-time
Total non-current assets	`AssetsNoncurrent`	$1.03B	USD	Point-in-time
Total non-current assets	`AssetsNoncurrent`	$1.07B	USD	Point-in-time
Total assets	`Assets`	$8.02B	USD	Point-in-time
Total assets	`Assets`	$8.65B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$236.91M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$262.40M	USD	Point-in-time
Accrued expenses and other payables	`AccruedLiabilitiesCurrent`	$558.05M	USD	Point-in-time
Accrued expenses and other payables	`AccruedLiabilitiesCurrent`	$385.98M	USD	Point-in-time
Deferred revenue, current portion	`ContractWithCustomerLiabilityCurrent`	$163.66M	USD	Point-in-time
Deferred revenue, current portion	`ContractWithCustomerLiabilityCurrent`	$187.41M	USD	Point-in-time
Tax payable	`TaxesPayableCurrent`	$38.51M	USD	Point-in-time
Tax payable	`TaxesPayableCurrent`	$21.39M	USD	Point-in-time
Operating lease liabilities, current portion	`OperatingLeaseLiabilityCurrent`	$21.93M	USD	Point-in-time
Operating lease liabilities, current portion	`OperatingLeaseLiabilityCurrent`	$22.89M	USD	Point-in-time
Research and development cost share liability, current portion	`ResearchAndDevelopmentCostShareLiabilityCurrentPortion`	$120.80M	USD	Point-in-time
Research and development cost share liability, current portion	`ResearchAndDevelopmentCostShareLiabilityCurrentPortion`	$120.97M	USD	Point-in-time
Short-term debt	`LongTermDebtCurrent`	2.72B	CNY	Point-in-time
Short-term debt	`LongTermDebtCurrent`	2.58B	CNY	Point-in-time
Short-term debt	`LongTermDebtCurrent`	$427.56M	USD	Point-in-time
Short-term debt	`LongTermDebtCurrent`	$407.39M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.38B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.60B	USD	Point-in-time
Long-term bank loans	`LongTermDebtNoncurrent`	$201.60M	USD	Point-in-time
Long-term bank loans	`LongTermDebtNoncurrent`	1.28B	CNY	Point-in-time
Long-term bank loans	`LongTermDebtNoncurrent`	1.29B	CNY	Point-in-time
Long-term bank loans	`LongTermDebtNoncurrent`	$202.11M	USD	Point-in-time
Deferred revenue, non-current portion	`ContractWithCustomerLiabilityNoncurrent`	$220.29M	USD	Point-in-time
Deferred revenue, non-current portion	`ContractWithCustomerLiabilityNoncurrent`	$204.37M	USD	Point-in-time
Operating lease liabilities, non-current portion	`OperatingLeaseLiabilityNoncurrent`	$43.04M	USD	Point-in-time
Operating lease liabilities, non-current portion	`OperatingLeaseLiabilityNoncurrent`	$39.99M	USD	Point-in-time
Deferred tax liabilities	`DeferredIncomeTaxLiabilitiesNet`	$14.22M	USD	Point-in-time
Deferred tax liabilities	`DeferredIncomeTaxLiabilitiesNet`	$14.17M	USD	Point-in-time
Research and development cost share liability, non-current portion	`ResearchAndDevelopmentCostShareLiabilityNoncurrentPortion`	$269.56M	USD	Point-in-time
Research and development cost share liability, non-current portion	`ResearchAndDevelopmentCostShareLiabilityNoncurrentPortion`	$247.57M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$54.23M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$51.83M	USD	Point-in-time
Total non-current liabilities	`LiabilitiesNoncurrent`	$759.58M	USD	Point-in-time
Total non-current liabilities	`LiabilitiesNoncurrent`	$803.41M	USD	Point-in-time
Total liabilities	`Liabilities`	$2.14B	USD	Point-in-time
Total liabilities	`Liabilities`	$2.40B	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Ordinary shares, US$0.0001 par value per share; 9,500,000,000 shares authorized; 1,334,805,269 and 1,334,804,281 shares issued and outstanding as of March 31, 2022 and December 31, 2021, respectively	`CommonStockValue`	$133.00K	USD	Point-in-time
Ordinary shares, US$0.0001 par value per share; 9,500,000,000 shares authorized; 1,334,805,269 and 1,334,804,281 shares issued and outstanding as of March 31, 2022 and December 31, 2021, respectively	`CommonStockValue`	$133.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$11.19B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$11.27B	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$17.45M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$17.95M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-4.97B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-5.40B	USD	Point-in-time
Total equity	`StockholdersEquity`	$5.89B	USD	Point-in-time
Total equity	`StockholdersEquity`	$6.24B	USD	Point-in-time
Total equity	`StockholdersEquity`	$3.87B	USD	Point-in-time
Total equity	`StockholdersEquity`	$4.00B	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$8.02B	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$8.65B	USD	Point-in-time

Income Statement 40 line items

Line Item	Tag	Value	Unit	Period
Total revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$605.87M	USD	1 Quarter
Total revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$306.63M	USD	1 Quarter
Cost of sales - product	`CostOfGoodsAndServicesSold`	$32.69M	USD	1 Quarter
Cost of sales - product	`CostOfGoodsAndServicesSold`	$65.24M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$389.92M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$320.73M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$182.11M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$294.57M	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssetsIncludedInOperatingExpenses`	$188.00K	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssetsIncludedInOperatingExpenses`	$188.00K	USD	1 Quarter
Total expenses	`CostsAndExpenses`	$535.71M	USD	1 Quarter
Total expenses	`CostsAndExpenses`	$749.91M	USD	1 Quarter
(Loss) income from operations	`OperatingIncomeLoss`	$70.17M	USD	1 Quarter
(Loss) income from operations	`OperatingIncomeLoss`	$-443.29M	USD	1 Quarter
Interest income (expense), net	`InterestIncomeExpenseNet`	$10.07M	USD	1 Quarter
Interest income (expense), net	`InterestIncomeExpenseNet`	$-4.18M	USD	1 Quarter
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$11.97M	USD	1 Quarter
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$-4.12M	USD	1 Quarter
(Loss) income before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$61.87M	USD	1 Quarter
(Loss) income before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-421.25M	USD	1 Quarter
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$-4.63M	USD	1 Quarter
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$13.03M	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$-434.27M	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$66.50M	USD	1 Quarter
Net (loss) income per share basic (in dollars per share)	`EarningsPerShareBasic`	$-0.33	USD	1 Quarter
Net (loss) income per share basic (in dollars per share)	`EarningsPerShareBasic`	$0.06	USD	1 Quarter
Net (loss) income per share diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.05	USD	1 Quarter
Net (loss) income per share diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.33	USD	1 Quarter
Weighted average shares outstandingbasic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.19B	shares	1 Quarter
Weighted average shares outstandingbasic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.33B	shares	1 Quarter
Weighted average shares outstanding - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.26B	shares	1 Quarter
Weighted average shares outstanding - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.33B	shares	1 Quarter
Net (loss) income per American Depositary Share ("ADS") basic (in dollars per share)	`EarningsPerAmericanDepositoryShareBasic`	$0.73	USD	1 Quarter
Net (loss) income per American Depositary Share ("ADS") basic (in dollars per share)	`EarningsPerAmericanDepositoryShareBasic`	$-4.24	USD	1 Quarter
Net (loss) income per American Depositary Share ("ADS") diluted (in dollars per share)	`EarningsPerAmericanDepositorySharePerShare`	$0.69	USD	1 Quarter
Net (loss) income per American Depositary Share ("ADS") diluted (in dollars per share)	`EarningsPerAmericanDepositorySharePerShare`	$-4.24	USD	1 Quarter
Weighted-average ADSs outstanding - basic (in shares)	`WeightedAverageNumberOfAmericanDepositorySharesOutstandingBasic`	102.46M	shares	1 Quarter
Weighted-average ADSs outstanding - basic (in shares)	`WeightedAverageNumberOfAmericanDepositorySharesOutstandingBasic`	91.46M	shares	1 Quarter
Weighted-average ADSs outstanding - diluted (in shares)	`WeightedAverageNumberOfAmericanDepositorySharesOutstandingDiluted`	96.73M	shares	1 Quarter
Weighted-average ADSs outstanding - diluted (in shares)	`WeightedAverageNumberOfAmericanDepositorySharesOutstandingDiluted`	102.46M	shares	1 Quarter

Cash Flow Statement 79 line items

Line Item	Tag	Value	Unit	Period
Net (loss) income	`NetIncomeLoss`	$-434.27M	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$66.50M	USD	1 Quarter
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$9.63M	USD	1 Quarter
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$16.60M	USD	1 Quarter
Share-based compensation expenses	`ShareBasedCompensation`	$65.56M	USD	1 Quarter
Share-based compensation expenses	`ShareBasedCompensation`	$45.83M	USD	1 Quarter
Unrealized losses on equity investments	`IncomeLossFromEquityMethodInvestments`	$-3.33M	USD	1 Quarter
Unrealized losses on equity investments	`IncomeLossFromEquityMethodInvestments`	$-16.97M	USD	1 Quarter
Acquired in-process research and development	`ResearchAndDevelopmentInProcess`	$8.50M	USD	1 Quarter
Acquired in-process research and development	`ResearchAndDevelopmentInProcess`	-	USD	1 Quarter
Amortization of research and development cost share liability	`AmortizationOfResearchAndDevelopmentFinancingLiability`	$-26.93M	USD	1 Quarter
Amortization of research and development cost share liability	`AmortizationOfResearchAndDevelopmentFinancingLiability`	$-21.82M	USD	1 Quarter
Deferred income tax benefits	`DeferredIncomeTaxesAndTaxCredits`	$-12.25M	USD	1 Quarter
Deferred income tax benefits	`DeferredIncomeTaxesAndTaxCredits`	$-5.29M	USD	1 Quarter
Other items, net	`OtherOperatingActivitiesCashFlowStatement`	$3.54M	USD	1 Quarter
Other items, net	`OtherOperatingActivitiesCashFlowStatement`	$5.26M	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-292.55M	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$23.66M	USD	1 Quarter
Inventories	`IncreaseDecreaseInInventories`	$3.00M	USD	1 Quarter
Inventories	`IncreaseDecreaseInInventories`	$-16.32M	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$17.95M	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$16.95M	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-73.18M	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-35.02M	USD	1 Quarter
Accrued expenses and other payables	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$-74.04M	USD	1 Quarter
Accrued expenses and other payables	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$-26.86M	USD	1 Quarter
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$150.25M	USD	1 Quarter
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$-39.68M	USD	1 Quarter
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$305.00K	USD	1 Quarter
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-1.71M	USD	1 Quarter
Net cash (used in) provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$125.09M	USD	1 Quarter
Net cash (used in) provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-236.56M	USD	1 Quarter
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$42.39M	USD	1 Quarter
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$45.13M	USD	1 Quarter
Purchases of investments	`PaymentsToAcquireInvestments`	$504.00K	USD	1 Quarter
Purchases of investments	`PaymentsToAcquireInvestments`	$764.16M	USD	1 Quarter
Proceeds from sale or maturity of investments	`ProceedsFromSaleOfAvailableForSaleSecuritiesDebt`	$331.03M	USD	1 Quarter
Proceeds from sale or maturity of investments	`ProceedsFromSaleOfAvailableForSaleSecuritiesDebt`	$1.11B	USD	1 Quarter
Purchase of in-process research and development	`PaymentsToPurchaseInProcessResearchAndDevelopment`	$75.00M	USD	1 Quarter
Purchase of in-process research and development	`PaymentsToPurchaseInProcessResearchAndDevelopment`	$8.50M	USD	1 Quarter
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$210.39M	USD	1 Quarter
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$291.95M	USD	1 Quarter
Proceeds from long-term loan	`ProceedsFromLongTermLinesOfCredit`	-	USD	1 Quarter
Proceeds from long-term loan	`ProceedsFromLongTermLinesOfCredit`	$10.66M	USD	1 Quarter
Proceeds from short-term loans	`ProceedsFromShortTermDebt`	$71.00M	USD	1 Quarter
Proceeds from short-term loans	`ProceedsFromShortTermDebt`	$50.00M	USD	1 Quarter
Repayment of short-term loans	`RepaymentsOfShortTermDebt`	-	USD	1 Quarter
Repayment of short-term loans	`RepaymentsOfShortTermDebt`	$73.15M	USD	1 Quarter
Proceeds from option exercises and employee share purchase plan	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$11.88M	USD	1 Quarter
Proceeds from option exercises and employee share purchase plan	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$25.75M	USD	1 Quarter
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-11.27M	USD	1 Quarter
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$107.42M	USD	1 Quarter
Effect of foreign exchange rate changes, net	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-4.06M	USD	1 Quarter
Effect of foreign exchange rate changes, net	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$9.00M	USD	1 Quarter
Net (decrease) increase in cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$520.40M	USD	1 Quarter
Net (decrease) increase in cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-28.44M	USD	1 Quarter
Cash, cash equivalents, and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.38B	USD	Point-in-time
Cash, cash equivalents, and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.39B	USD	Point-in-time
Cash, cash equivalents, and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.91B	USD	Point-in-time
Cash, cash equivalents, and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.35B	USD	Point-in-time
Cash, cash equivalents, and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.38B	USD	Point-in-time
Cash, cash equivalents, and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.39B	USD	Point-in-time
Cash, cash equivalents, and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.91B	USD	Point-in-time
Cash, cash equivalents, and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.35B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$4.35B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.90B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$4.38B	USD	Point-in-time
Short-term restricted cash	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$330.00K	USD	Point-in-time
Short-term restricted cash	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$328.00K	USD	Point-in-time
Short-term restricted cash	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$305.00K	USD	Point-in-time
Long-term restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$8.28M	USD	Point-in-time
Long-term restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$6.96M	USD	Point-in-time
Long-term restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$6.88M	USD	Point-in-time
Income taxes paid	`IncomeTaxesPaidNet`	$736.00K	USD	1 Quarter
Income taxes paid	`IncomeTaxesPaidNet`	$478.00K	USD	1 Quarter
Interest paid	`InterestPaidNet`	$6.62M	USD	1 Quarter
Interest paid	`InterestPaidNet`	$6.93M	USD	1 Quarter
Acquisitions of equipment included in accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	$62.74M	USD	1 Quarter
Acquisitions of equipment included in accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	$30.91M	USD	1 Quarter

Stockholders Equity 21 line items

Line Item	Tag	Value	Unit	Period
Balance at the beginning of period (in shares)	`CommonStockSharesOutstanding`	1.33B	shares	Point-in-time
Balance at the beginning of period (in shares)	`CommonStockSharesOutstanding`	1.33B	shares	Point-in-time
Balance at the beginning of period	`StockholdersEquity`	$5.89B	USD	Point-in-time
Balance at the beginning of period	`StockholdersEquity`	$6.24B	USD	Point-in-time
Balance at the beginning of period	`StockholdersEquity`	$3.87B	USD	Point-in-time
Balance at the beginning of period	`StockholdersEquity`	$4.00B	USD	Point-in-time
Cost from issuance of ordinary shares	`AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts`	$152.00K	USD	1 Quarter
Exercise of options, ESPP and release of Restricted Share Units ("RSUs")	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$25.75M	USD	1 Quarter
Exercise of options, ESPP and release of Restricted Share Units ("RSUs")	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$11.88M	USD	1 Quarter
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$65.56M	USD	1 Quarter
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$45.83M	USD	1 Quarter
Other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-3.74M	USD	1 Quarter
Other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-496.00K	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$-434.27M	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$66.50M	USD	1 Quarter
Balance at the end of period	`StockholdersEquity`	$5.89B	USD	Point-in-time
Balance at the end of period	`StockholdersEquity`	$6.24B	USD	Point-in-time
Balance at the end of period	`StockholdersEquity`	$3.87B	USD	Point-in-time
Balance at the end of period	`StockholdersEquity`	$4.00B	USD	Point-in-time
Balance at the end of period (in shares)	`CommonStockSharesOutstanding`	1.33B	shares	Point-in-time
Balance at the end of period (in shares)	`CommonStockSharesOutstanding`	1.33B	shares	Point-in-time

Comprehensive Income 10 line items

Line Item	Tag	Value	Unit	Period
Net (loss) income	`NetIncomeLoss`	$-434.27M	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$66.50M	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$9.37M	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$-3.76M	USD	1 Quarter
Pension liability adjustments	`OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent`	$-497.00K	USD	1 Quarter
Pension liability adjustments	`OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent`	-	USD	1 Quarter
Unrealized holding loss, net	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$-9.87M	USD	1 Quarter
Unrealized holding loss, net	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$-473.00K	USD	1 Quarter
Comprehensive (loss) income	`ComprehensiveIncomeNetOfTax`	$-434.77M	USD	1 Quarter
Comprehensive (loss) income	`ComprehensiveIncomeNetOfTax`	$62.76M	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.